---
title: "Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296267639.md"
description: "Amgen Inc. (AMGN) shares rose 1.41% to $425.28 on Tuesday, marking a second consecutive day of gains and hitting a new 52-week high. Despite these daily gains, Amgen underperformed relative to competitors like Johnson & Johnson, Pfizer, and AbbVie during a broader market decline where the S&P 500 and Dow Jones fell. Trading volume remained below its 50-day average."
datetime: "2026-08-18T20:34:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296267639.md)
  - [en](https://longbridge.com/en/news/296267639.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296267639.md)
---

# Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Amgen Inc. (AMGN) advanced 1.41% to $425.28 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

This was the stock's second consecutive day of gains.

Amgen Inc. hit a new 52-week high, surpassing its previous peak of $421.79, which the company achieved on August 11th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 3.33% to $271.11, Pfizer Inc. (PFE) rose 1.41% to $27.25, and AbbVie Inc. (ABBV) rose 3.43% to $258.92.

Trading volume (2.6 M) remained 235,052 below its 50-day average volume of 2.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-18-26 1634ET

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [TScan Therapeutics Faces Loss of Key Amgen Partnership](https://longbridge.com/en/news/296272693.md)
- [Rocket Companies director Sarah Watterson files Form 3 initial beneficial ownership statement](https://longbridge.com/en/news/296141298.md)
- [Teleperformance executive committee member sells EUR 228,410](https://longbridge.com/en/news/295958206.md)
- [Andar Capital Management HK Ltd Takes $4.32 Million Position in FormFactor, Inc. $FORM](https://longbridge.com/en/news/296068767.md)
- [Solventum files Form 3 for SVP, Controller and CAO Neil Zieselman](https://longbridge.com/en/news/296265352.md)